Protocol summary

Study aim
This study is designed to investigate the effect of tDCS (Transcranial Direct Current Stimulation) on reducing the craving, dependency and long-term relapse in methamphetamine-dependent patients.
Design
This is a double blinded clinical trial with a sample size of 60 people, which is randomly divided into two groups of 30 patients in intervention and control groups.
Settings and conduct
Clinical trials are conducted at the Institute of Peyrovanhemat. The intervention takes place for two weeks, 5 sessions weekly, and participants in both groups are followed up for 6 months after the first intervention. In this research, only the operator of the device is aware of the members of the intervention and control groups, and the participants, campus staff and even the researcher are unaware of the identity of the participants in each group.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Using methamphetamine for at least 6 months as the main drug based on DSM-V2, Usage history at least 3 times a week during the last 6 months, Male gender and Age range of 21-50 years. Exclusion criteria: Female gender and History of brain damage, epilepsy, brain surgery and tumor
Intervention groups
The test group will receive 10 sessions (2-weeks, 5-sessions every week) of 2-mA electric brain stimulation for 20 minutes, while the control group will experience sham, in the same condition in the same sessions.
Main outcome variables
The sustain effect of tDCS on methamphetamine craving; the effect of tDCS on changing the cognitive function of methamphetamine users; Does prescribing tDCS for ten consecutive sessions lead to a permanent decline of methamphetamine craving?

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20170822035838N2
Registration date: 2018-03-21, 1397/01/01
Registration timing: prospective

Last update: 2018-03-21, 1397/01/01
Update count: 0
Registration date
2018-03-21, 1397/01/01
Registrant information
Name
Mehrdad Akhavan Behbahany
Name of organization / entity
Institute for Cognitive Science Studies
Country
Iran (Islamic Republic of)
Phone
+98 21 7629 1130
Email address
akhavan_m@iricss.org
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-04-03, 1397/01/14
Expected recruitment end date
2018-09-05, 1397/06/14
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Cumulative and Booster Effects of tDCS Sessions on Drug Craving, lapse and Cognitive Impairments in Methamphetamine Users, A Randomized Double Blind Clinical Trial study
Public title
Studying he long-term Effects of Brain Electrical stimulation on the Rate of Craving and Return to Methamphetamine Consumption
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
1. Using methamphetamine for at least 6 months as the main drug based on DSM-V2 2. Usage history at least 3 times a week during the last 6 months 3. Male gender 4. Age range of 21-50 years
Exclusion criteria:
1. History of brain damage, epilepsy, brain surgery and tumor
Age
From 21 years old to 50 years old
Gender
Male
Phase
N/A
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
The statistical population of this study is methamphetamine users. Due to lack of access to all subjects in the population studied, we will sample from consumers who go to Peyrovanehemat Institute for disconnecting the drug. After applying the criteria for entry into the study and basic craving assessment tests, 71 qualified participants are identified. Obviously, at this stage, no choice has taken place, and only 71 first will be selected. The sample size was calculated using the Cochran sampling formula, according to which the maximum sample size for this study was 60. Therefore, 11 of these 71 people should be randomly excluded from the study. In this phase of randomization, the Random allocation rule is used. People are divided into three groups: The first 30 people will enter the intervention group and the second 30 people will go to the control group. The third group containing 11 people are going to be excluded. For this purpose, 71 red and green balls will be placed in a packed dish, and one of the Campus personnel will pick up a ball for each person. The 11 green balls are people who will be excluded. Red balls are numbered from 1 to 60. Couple numbers enter the intervention group and the single numbers will be entered into the control group. In this way, the balls are randomly and without substitution selected for each subject and then the No. and color is registered for the operator. In order to accurately execute the random allocation process and prevent any bias in this study, each stage of the test was conducted by a different person. The researcher tracks 71 entries to the study according to the criteria in the research. Briefly, One of the camp personnel perform the randomization phase (selecting of the balls). Next the operator will execute the test protocol based on the assigned No. to the subjects. Thus, the subjects under study, the camp's personnel and researcher are not aware of the control or intervention groups of subjects, and only the operator knows which subject is in which groups. Inevitably, the researcher is aware of the process of research, but the procedure will be such that the researcher leaves the Camp after the selection of 71 and is not included in the performance of conducting the investigation, Therefore, his data will not ruin the randomization process of the research.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study will be double blind because in this research only the operator of the device is aware of the members of the intervention and control groups and the participants, the camp's employees, and even the self-researcher are unaware of the identity of the participants in each group. Information from volunteers is also entered by another person in a table and analyzed that has no information about the course of the illness
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran University of Medical Science
Street address
No 23, Before Poursina Street, Azar 16th street, Keshavarz Boulevard, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
147863181
Approval date
2016-12-31, 1395/10/11
Ethics committee reference number
IR.TUMS.VCR.REC.1395.1346

Health conditions studied

1

Description of health condition studied
Methamphetamine dependency
ICD-10 code
F15.2
ICD-10 code description
Other stimulant dependence

Primary outcomes

1

Description
Basic Met Craving
Timepoint
Before the intervention, 72 hours after the intervention sessions, up to 6 months after the end of the intervention
Method of measurement
Drug Desire Questionnaire (DDQ)

Secondary outcomes

1

Description
Cue-induced craving
Timepoint
Before the intervention, 72 hours after the intervention sessions, up to 6 months after the end of the intervention
Method of measurement
Drug Desire Questionnaire (DDQ)

Intervention groups

1

Description
Intervention group: Direct and constant current is generated by a battery and transferred by a pair of 4.5×5 cm (22.5 cm square) electrodes. Electrodes are standard carbonic, covered with a normal saline socked sponge cases. The intervention group receive tDCS for 10 sessions. The anode electrode is placed on right Dorsolateral prefrontal cortex (rDLPFC) and cathode on the forehead above the left eye (Supraorbital) and 2 mA current is passed through patient's brain for 20 min. At the end of the sessions, whenever participants have methamphetamine craving, they will receive one session of tDCS.
Category
Rehabilitation

2

Description
Control group: This group will not receive brain stimulation (tDCS). But to create placebo effect, we place the anode and cathode electrodes on the same position as we have done for intervention group. Here there is no brain electric stimulation and the electric current generator is only ramping up to 2 mA in 30 seconds, then gradually ramping down to 0 mA over the period of 1 minute, and then turned off but the electrodes will remain on the scalp for 20 minutes. Of course, subjects will not be informed that the device is turned off. At the end of the sessions, whenever a participant have methamphetamine craving, he will receive this placebo again.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Peyrovanehemat Ins
Full name of responsible person
Mr Jajuee
Street address
No 18, Taheri alley, Javid St, Moradi St, Taavon St, Shahr-e-Ziba Square
City
Tehran
Province
Tehran
Postal code
1486773311
Phone
+98 21 4415 5938
Fax
+98 21 4413 3913
Email
Shahabedinf@yahoo.com
Web page address
http://www.phemat.ir/

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
پژوهشکده علوم شناختی
Full name of responsible person
Dr Peyman Hasani Abharian
Street address
Pardis New City (15 KMs North East of Tehran), 4th Phase, Safir Omid Blvd. Pazhouheshkadeh Blvd.
City
Tehran
Province
Tehran
Postal code
13950809172385689
Phone
+98 21 7629 1130
Fax
+98 21 7629 1140
Email
icss@iricss.org
Web page address
http://iricss.org
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
پژوهشکده علوم شناختی
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Persons

Person responsible for general inquiries

Contact
Name of organization / entity
Islamic Azad University, South Tehran Branch
Full name of responsible person
Saber Hassanloo
Position
Master of Science in Management
Latest degree
Master
Other areas of specialty/work
Biomedical Engineering
Street address
Saleh Charity Clinic - No. 14- Meraj alley - Behesht St.- Khayyam St. - Al-Ayraq - Square of Imam Khomeini
City
Tehran
Province
Tehran
Postal code
1114785413
Phone
+98 21 5580 3121
Fax
+98 21 5561 1121
Email
saberhasanlou@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Brain and Cognition Clinic
Full name of responsible person
Dr Peyman Hasani Abharian
Position
Clinic Boss
Latest degree
Ph.D.
Other areas of specialty/work
Neuroscience
Street address
Brain and cognition Clinic, No 33, East Zartosht St, Valiassr Square
City
Tehran
Province
Tehran
Postal code
13950809172385689
Phone
+98 21 8880 2063
Fax
+98 21 8890 0526
Email
abharian1972@yahoo.com
Web page address
http://bacogc.com/

Person responsible for updating data

Contact
Name of organization / entity
Islamic Azad University, South Tehran Branch
Full name of responsible person
Saber Hassanloo
Position
Master of Science in Management
Latest degree
Master
Other areas of specialty/work
Biomedical Engineering
Street address
Saleh Charity Clinic - No. 14- Meraj alley - Behesht St.- Khayyam St. - Square of Imam Khomeini
City
Tehran
Province
Tehran
Postal code
1114785413
Phone
+98 21 5580 3121
Fax
+98 21 5561 1121
Email
saberhasanlou@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
The documentations of this study include reliable questionnaires for assessing the degree of patient craving, useful tests of cognitive assessments, the protocol of working with the device and our proposed methods for following up patients' rehab. All of these, of course will be published after following steps.
When the data will become available and for how long
The study is to be published as soon as the analyzes are completed and the results are published in one of the prestigious academic journals. The primary article will include how to sample patients, the correct method of randomization and the implementation of a two-way blind trial, regardless of the results and initial variables. Naturally, there is no possibility of publishing the initial data at this stage, since we want to extracted more results by various analyzes and publish other titles of articles. The remaining data will be publicly available for up to 6 months after the publication of the second article, because the target group of this study is physicians and psychologists working in the field of addiction, and if we want to win their trust, we should provide sufficient documentation for them.
To whom data/document is available
There are no restrictions for applicants
Under which criteria data/document could be used
Raw data would be relatively large since we will have a six-month follow-up a large number of patients with a variety of questionnaires and cognitive tests. Possibly, re-analyzing this information with other statistical methods would be useful. Since the purpose of this study is to extend the use of this device in rehab of the patients, who are trying to discontinue using Met, there is no limit to the review of the method of work and re-analyzing of information and documentation, and the researcher wants to be aware of such meaningful results.
From where data/document is obtainable
Contacting the researcher or Dr Abharian by e-mail is my suggested method for researchers and enthusiasts, and of course doctors and psychologists who want to learn more about this.
What processes are involved for a request to access data/document
Sending a college email is sufficient for the researcher, if not, sending a resume and phone and address to the workplace is necessary for my research team to be able to review the application.
Comments
Loading...